$CSRA (CSRA Inc.)

$CSRA {{ '2016-05-25T22:26:14+0000' | timeago}} • Webcast

William Loomis of Stifel Nicolaus & Company asks about $CSRA's free cash flow assumptions. CFO David Keffer said the long term guidance is at or above the level of net income. This is consistent with the midpoint of the FY17 guidance which is $325MM.

$CSRA {{ '2017-12-21T16:17:41+0000' | timeago}} • Announcement

$CSRA's BoD declared a quarterly dividend of $0.10 per share on its common stock. The dividend will be paid on Jan. 25, 2018 to stockholders of record at the close of business on Jan. 4, 2018.

$CSRA {{ '2017-11-07T22:28:13+0000' | timeago}} • Announcement

$CSRA's backlog of signed business orders at the end of 2Q18 was $17.7Bil, of which $2.7Bil was funded. On a sequential basis, total backlog was up 14%, while funded backlog was up 11% for the quarter.

$CSRA {{ '2017-11-07T22:25:57+0000' | timeago}} • Announcement

For FY18, $CSRA expects revenue to be in the range of $5-5.2Bil and adjusted diluted EPS in the range of $1.88-2.00 per share. Adjusted EBITDA for FY18 is expected in the range of $770-800MM, while free cash flow expectation is of $330-380MM.

$CSRA {{ '2017-11-07T22:19:23+0000' | timeago}} • Announcement

IT services provider $CSRA reported flat YoY earnings for 2Q18. Net income remained flat at $76MM or $0.46 per share, while revenue for the quarter increased marginally by 1% to $1.27Bil. On an adjusted basis, $CSRA declined 10% to $0.46 per share from $0.51 per share a year earlier.

$CSRA {{ '2017-11-07T21:56:25+0000' | timeago}} • Infographic

$CSRA CSRA Inc. Earnings AlphaGraphic: Q2 2018 Highlights

$CSRA {{ '2017-05-24T22:03:45+0000' | timeago}} • Webcast

$CSRA stated that regarding the drivers of revenue acceleration in 2H18, the company is seeing a healthy pipeline of new work. Additionally, on head count growth and utilization, $CSRA has seen steady labor utilization rates in recent quarters and expects the same moving forward.

$CSRA {{ '2017-05-24T21:53:24+0000' | timeago}} • Webcast

$CSRA expects quarterly revenue and earnings to step up through 2018, with 1Q18 being slightly below 4Q17, driven by the continued wind-downs of some contracts and equipment purchases pulled forward into 4Q17.

$CSRA {{ '2017-05-24T21:30:18+0000' | timeago}} • Webcast

$CSRA won $3.8Bil in new business in FY17, which the company believes should yield north of $700MM in annual revenue when fully ramped. In 4Q17, $CSRA had its highest number of hires to date, including large number of talented millenials attracted to next generation technology. The company expects this trend to strengthen in FY18.

$CSRA {{ '2017-05-24T20:48:55+0000' | timeago}} • Announcement

For 4Q17, $CSRA's operating cash flow was $50MM, and free cash flow was $62MM. "Our book-to-bill ratio of 1.1x marked the ninth straight quarter with bookings at or above revenue," said CEO Larry Prior.

$CSRA {{ '2017-05-24T20:46:30+0000' | timeago}} • Announcement

For FY18, $CSRA sees a revenue of $5.0-5.2Bil, adjusted EBITDA of $770-800MM and free cash flow of $330-380MM, generating an adjusted diluted earnings of $1.88-2.00 per share.

$CSRA {{ '2017-05-24T20:41:45+0000' | timeago}} • Announcement

Revenue for $CSRA fell 3% to $1.25Bil in 4Q17, as earnings moved up to $0.22 per diluted share from last year's loss of $0.44 a share. Net income attributable to stockholders was $37MM, up from a loss of $72MM, with bookings totaling $1.3Bil in the quarter.

$CSRA {{ '2017-02-07T22:23:12+0000' | timeago}} • Announcement

$CSRA lowered its FY17 revenue outlook to $4.96-5.01Bil from $5-5.2Bil and its adjusted EBITDA estimate to $857-867MM from $870-905MM. The company narrowed its FY17 adjusted EPS forecast to $1.98-2.02 from $1.91-2.04. $CSRA still predicts free cash flow of $300-350MM. The estimate for adjusted EBITDA and EPS assumes pension income of $92MM.

$CSRA {{ '2017-02-07T22:18:32+0000' | timeago}} • Announcement

$CSRA's bookings totaled $1.9Bil in 3Q17, representing a book-to-bill ratio of 1.5 times. The company's backlog of signed business orders at the end of 3Q17 was $15.8Bil, of which $2.7Bil was funded. Total backlog increased 3% compared to the pro forma backlog at the end of 3Q16.

$CSRA {{ '2017-02-07T22:16:15+0000' | timeago}} • Announcement

$CSRA reported a rise in 3Q17 earnings driven by higher revenue. Net income rose to $128MM or $0.76 per share from $51MM or $0.29 per share last year. Revenue grew 18% to $1.22Bil, as a result of merger with SRA International. Pro forma EPS remained unchanged at $0.48.

$CSRA {{ '2016-12-27T16:05:09+0000' | timeago}} • Announcement

$CSRA's subsidiary DynPort Vaccine Co. (DVC) received multiple-award, indefinite-delivery, indefinite-quantity (IDIQ) contract to manage variety of medical product development initiatives for National Institute of Allergy and Infectious Diseases (NIAID). DVC is one of 4 awardees to get IDIQ valued up to $159MM, with 10 years performance period.

$CSRA {{ '2016-12-21T18:03:40+0000' | timeago}} • Announcement

$CSRA received a task order valued at $744MM to provide a wide-range of services supporting the Command, Control, Communications, Computers, Intelligence, Surveillance and Reconnaissance (C4ISR) systems used by U.S. Army coalition forces around the world.

$CSRA {{ '2016-11-21T14:27:50+0000' | timeago}} • Announcement

$CSRA received a re-competed contract with the Department of Homeland Security's Office of Cybersecurity and Communications to provide a broad range of technical services and expertise. The single-award contract is valued at more than $52MM over a 4-year period.

$CSRA {{ '2016-11-09T22:15:34+0000' | timeago}} • Announcement

$CSRA still expects FY17 revenue of $5-5.2Bil and adjusted EPS of $1.91-2.04. The company maintained its 2017 adjusted EBITDA guidance of $870-905MM and free cash flow outlook of $300-350MM. The estimate for adjusted EBITDA and EPS assumes pension income of $96MM, consistent with amounts recorded in 1H17.

$CSRA {{ '2016-11-09T22:13:18+0000' | timeago}} • Announcement

$CSRA's bookings for 2Q17 totaled $2.4Bil, representing a book-to-bill ratio of 1.9x. The company's backlog of signed business orders at end of 2Q17 was $15.5Bil, of which $3Bil was funded. Total backlog increased 2% compared to pro forma backlog at end of 2Q16.

$CSRA {{ '2016-11-09T22:09:39+0000' | timeago}} • Announcement

Information technology services provider $CSRA reported a rise in 2Q17 earnings as merger with SRA International drove revenue higher by 30%. Net income rose to $76MM or $0.46 per share from $48MM or $0.35 per share last year. Revenue grew to $1.26Bil from $969MM. Adjusted EPS increased to $0.56 from $0.53.

Recent Transcripts

INFO (IHS Markit Ltd.)
Tuesday, January 16 2018 - 1:00pm
ORCL (Oracle Corporation)
Thursday, December 14 2017 - 10:00pm
AOBC (American Outdoor Brands Corporation)
Thursday, December 7 2017 - 10:00pm
HOME (At Home Group Inc.)
Wednesday, November 29 2017 - 9:30pm
VVV (Valvoline Inc.)
Thursday, November 9 2017 - 2:00pm
CSRA (CSRA Inc.)
Tuesday, November 7 2017 - 10:00pm
ICFI (ICF International Inc.)
Thursday, November 2 2017 - 8:30pm
BHF (Brighthouse Financial, Inc.)
Thursday, November 2 2017 - 4:00pm
CACI (CACI International Inc.)
Thursday, November 2 2017 - 12:30pm
DWDP (DowDuPont Inc.)
Thursday, November 2 2017 - 12:00pm
ACXM (Acxiom Corporation)
Wednesday, November 1 2017 - 9:00pm
APTS (Preferred Apartment Communities, Inc.)
Tuesday, October 31 2017 - 3:00pm
BIVV (Bioverativ Inc.)
Friday, October 27 2017 - 12:00pm
MSFT (Microsoft Corporation)
Thursday, October 26 2017 - 9:30pm
ITGR (Integer Holdings Corporation)
Thursday, October 26 2017 - 9:00pm
GOOGL (Alphabet Inc.)
Thursday, October 26 2017 - 8:30pm
LLL (L-3 Communications Holdings Inc.)
Thursday, October 26 2017 - 3:00pm
FCN (FTI Consulting, Inc.)
Thursday, October 26 2017 - 1:00pm
ADS (Alliance Data Systems Corporation)
Thursday, October 19 2017 - 12:30pm
INFO (IHS Markit Ltd.)
Tuesday, September 26 2017 - 12:00pm

AlphaGraphics you may like